US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist
  • 0.871
  • -0.130-12.95%
Close Nov 4 16:00 ET
  • 0.870
  • 0.000-0.05%
Post 16:05 ET
47.38MMarket Cap-1674P/E (TTM)

Cytosorbents Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
9.53%8.84M
13.65%8.99M
5.88%31.08M
-3.84%7.35M
19.98%7.75M
10.12%8.07M
-0.18%7.91M
-26.80%29.36M
-21.20%7.64M
-27.40%6.46M
Operating revenue
9.53%8.84M
13.65%8.99M
5.88%31.08M
-3.84%7.35M
19.98%7.75M
10.12%8.07M
-0.18%7.91M
-26.80%29.36M
-21.20%7.64M
-27.40%6.46M
Cost of revenue
-0.30%3.39M
-19.49%3.22M
0.01%13.96M
-7.61%3.36M
-28.70%3.2M
-4.18%3.4M
75.36%3.99M
26.33%13.96M
16.35%3.63M
82.46%4.49M
Gross profit
16.70%5.45M
47.45%5.77M
11.19%17.13M
-0.42%3.99M
131.12%4.55M
23.55%4.67M
-30.65%3.92M
-46.99%15.4M
-39.03%4.01M
-69.42%1.97M
Operating expense
-21.02%8.87M
-9.39%10.7M
3.01%48.34M
28.64%13.33M
8.32%11.9M
-7.48%11.23M
-12.13%11.81M
-9.42%46.93M
-35.77%10.36M
-7.25%10.99M
Selling and administrative expenses
-5.69%8.4M
1.26%9.25M
1.98%37.87M
21.18%10.56M
-1.46%9.21M
-2.30%8.91M
-8.32%9.13M
-3.50%37.14M
-21.40%8.71M
10.70%9.34M
-General and administrative expense
-5.69%8.4M
1.26%9.25M
1.98%37.87M
21.18%10.56M
-1.46%9.21M
-2.30%8.91M
-8.32%9.13M
-3.50%37.14M
-21.40%8.71M
10.70%9.34M
Research and development costs
-58.58%1.52M
-46.65%2.25M
4.03%15.73M
20.42%4.1M
13.95%3.75M
-12.30%3.67M
-0.68%4.21M
-7.70%15.12M
-44.57%3.4M
-22.81%3.29M
Other operating expenses
21.92%-1.05M
48.24%-796.77K
1.21%-5.26M
24.52%-1.32M
35.90%-1.06M
-15.76%-1.35M
-100.72%-1.54M
-74.32%-5.33M
-61.25%-1.75M
-92.03%-1.65M
Operating profit
47.88%-3.42M
37.59%-4.93M
0.99%-31.21M
-46.96%-9.34M
18.49%-7.35M
21.51%-6.56M
-1.29%-7.89M
-38.59%-31.52M
33.52%-6.36M
-66.80%-9.02M
Net non-operating interest income expense
-1,941.70%-180.1K
89.47%-6.65K
-219.08%-157.89K
-197.17%-52.23K
-171.88%-33.67K
-136.80%-8.82K
-886.97%-63.17K
373.44%132.6K
337.19%53.75K
266.95%46.85K
Total other finance cost
1,941.70%180.1K
-89.47%6.65K
219.08%157.89K
197.17%52.23K
171.88%33.67K
136.80%8.82K
886.97%63.17K
-373.44%-132.6K
-337.19%-53.75K
-266.95%-46.85K
Other net income (expense)
-231.15%-544.23K
-326.70%-1.43M
181.32%2.05M
-38.23%2.75M
43.98%-1.81M
116.30%414.97K
153.15%628.88K
2.41%-2.52M
1,000.51%4.44M
-218.87%-3.23M
Gain on sale of security
-231.15%-544.23K
-315.79%-1.43M
179.61%1.95M
-40.61%2.68M
43.98%-1.81M
116.45%414.97K
154.45%660.68K
5.02%-2.45M
1,015.53%4.52M
-218.87%-3.23M
Other non- operating income (expenses)
----
----
243.76%96.75K
183.30%61.75K
----
----
-205.99%-31.8K
---67.3K
---74.13K
---29
Income before tax
32.67%-4.14M
13.21%-6.36M
13.52%-29.32M
-257.70%-6.65M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-34.04%-33.91M
81.49%-1.86M
-90.45%-12.2M
Income tax
0
0
25.52%-813.74K
25.52%-813.74K
0
0
0
-48.45%-1.09M
-48.45%-1.09M
0
Net income
32.67%-4.14M
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
-90.45%-12.2M
Net income continuous Operations
32.67%-4.14M
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
-90.45%-12.2M
Minority interest income
Net income attributable to the parent company
32.67%-4.14M
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
-90.45%-12.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
32.67%-4.14M
13.21%-6.36M
13.12%-28.51M
-661.61%-5.83M
24.65%-9.19M
43.44%-6.15M
18.30%-7.33M
-33.61%-32.81M
91.77%-766.13K
-90.45%-12.2M
Basic earnings per share
42.86%-0.08
29.41%-0.12
14.67%-0.64
-1,100.00%-0.12
25.00%-0.21
44.00%-0.14
19.05%-0.17
-31.58%-0.75
95.24%-0.01
-86.67%-0.28
Diluted earnings per share
42.86%-0.08
29.41%-0.12
14.67%-0.64
-1,100.00%-0.12
25.00%-0.21
44.00%-0.14
19.05%-0.17
-31.58%-0.75
95.24%-0.01
-86.67%-0.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 9.53%8.84M13.65%8.99M5.88%31.08M-3.84%7.35M19.98%7.75M10.12%8.07M-0.18%7.91M-26.80%29.36M-21.20%7.64M-27.40%6.46M
Operating revenue 9.53%8.84M13.65%8.99M5.88%31.08M-3.84%7.35M19.98%7.75M10.12%8.07M-0.18%7.91M-26.80%29.36M-21.20%7.64M-27.40%6.46M
Cost of revenue -0.30%3.39M-19.49%3.22M0.01%13.96M-7.61%3.36M-28.70%3.2M-4.18%3.4M75.36%3.99M26.33%13.96M16.35%3.63M82.46%4.49M
Gross profit 16.70%5.45M47.45%5.77M11.19%17.13M-0.42%3.99M131.12%4.55M23.55%4.67M-30.65%3.92M-46.99%15.4M-39.03%4.01M-69.42%1.97M
Operating expense -21.02%8.87M-9.39%10.7M3.01%48.34M28.64%13.33M8.32%11.9M-7.48%11.23M-12.13%11.81M-9.42%46.93M-35.77%10.36M-7.25%10.99M
Selling and administrative expenses -5.69%8.4M1.26%9.25M1.98%37.87M21.18%10.56M-1.46%9.21M-2.30%8.91M-8.32%9.13M-3.50%37.14M-21.40%8.71M10.70%9.34M
-General and administrative expense -5.69%8.4M1.26%9.25M1.98%37.87M21.18%10.56M-1.46%9.21M-2.30%8.91M-8.32%9.13M-3.50%37.14M-21.40%8.71M10.70%9.34M
Research and development costs -58.58%1.52M-46.65%2.25M4.03%15.73M20.42%4.1M13.95%3.75M-12.30%3.67M-0.68%4.21M-7.70%15.12M-44.57%3.4M-22.81%3.29M
Other operating expenses 21.92%-1.05M48.24%-796.77K1.21%-5.26M24.52%-1.32M35.90%-1.06M-15.76%-1.35M-100.72%-1.54M-74.32%-5.33M-61.25%-1.75M-92.03%-1.65M
Operating profit 47.88%-3.42M37.59%-4.93M0.99%-31.21M-46.96%-9.34M18.49%-7.35M21.51%-6.56M-1.29%-7.89M-38.59%-31.52M33.52%-6.36M-66.80%-9.02M
Net non-operating interest income expense -1,941.70%-180.1K89.47%-6.65K-219.08%-157.89K-197.17%-52.23K-171.88%-33.67K-136.80%-8.82K-886.97%-63.17K373.44%132.6K337.19%53.75K266.95%46.85K
Total other finance cost 1,941.70%180.1K-89.47%6.65K219.08%157.89K197.17%52.23K171.88%33.67K136.80%8.82K886.97%63.17K-373.44%-132.6K-337.19%-53.75K-266.95%-46.85K
Other net income (expense) -231.15%-544.23K-326.70%-1.43M181.32%2.05M-38.23%2.75M43.98%-1.81M116.30%414.97K153.15%628.88K2.41%-2.52M1,000.51%4.44M-218.87%-3.23M
Gain on sale of security -231.15%-544.23K-315.79%-1.43M179.61%1.95M-40.61%2.68M43.98%-1.81M116.45%414.97K154.45%660.68K5.02%-2.45M1,015.53%4.52M-218.87%-3.23M
Other non- operating income (expenses) --------243.76%96.75K183.30%61.75K---------205.99%-31.8K---67.3K---74.13K---29
Income before tax 32.67%-4.14M13.21%-6.36M13.52%-29.32M-257.70%-6.65M24.65%-9.19M43.44%-6.15M18.30%-7.33M-34.04%-33.91M81.49%-1.86M-90.45%-12.2M
Income tax 0025.52%-813.74K25.52%-813.74K000-48.45%-1.09M-48.45%-1.09M0
Net income 32.67%-4.14M13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K-90.45%-12.2M
Net income continuous Operations 32.67%-4.14M13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K-90.45%-12.2M
Minority interest income
Net income attributable to the parent company 32.67%-4.14M13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K-90.45%-12.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 32.67%-4.14M13.21%-6.36M13.12%-28.51M-661.61%-5.83M24.65%-9.19M43.44%-6.15M18.30%-7.33M-33.61%-32.81M91.77%-766.13K-90.45%-12.2M
Basic earnings per share 42.86%-0.0829.41%-0.1214.67%-0.64-1,100.00%-0.1225.00%-0.2144.00%-0.1419.05%-0.17-31.58%-0.7595.24%-0.01-86.67%-0.28
Diluted earnings per share 42.86%-0.0829.41%-0.1214.67%-0.64-1,100.00%-0.1225.00%-0.2144.00%-0.1419.05%-0.17-31.58%-0.7595.24%-0.01-86.67%-0.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data